Anelixis Therapeutics Competitors and Similar CompaniesClear all

Anelixis Therapeutics's competitors and similar companies include Serum Institute of India, Shandong Saito Biotechnology, The Searle Company and Bicycle Therapeutics.

	Anelixis Therapeutics Anelixis Therapeutics is a biotechnology company developing therapies for patients with neurodegenerative and autoimmune diseases.	Serum Institute of India Serum Institute of India is a biotechnology company.	Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.	The Searle Company The Searle Company is a pharmaceutical company.	Bicycle Therapeutics Bicycle Therapeutics is a clinical-stage biopharmaceutical company that develops cancer therapies.
Founding Date	Founding Date 2013	Founding Date 1966	Founding Date 2010	Founding Date 1965	Founding Date 2009
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development
Locations	Locations HQ	Locations Pune, IN HQ Mumbai, IN Pune, IN	Locations Heze, CN HQ	Locations Karachi, PK HQ Karachi, PK Karachi, PK Lahore, PK	Locations Cambridge, GB HQ Cambridge, US
Employees	Employees 9	Employees 5,3831% increase	Employees 95920% decrease	Employees 2,4241% increase	Employees 305
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 708.6 m	Valuation ($) N/A	Valuation ($) 1.7 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥961.3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $72.6m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income (¥84.7m) (FY, 2025)	Net income N/A	Net income ($219m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 6.9m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 89.4m